Summary
The effect of long-term treatment on the absorption and dispsoition of metoprolol has been evaluated in 8 healthy, non-smoking, elderly individuals (mean age 74.5 years) and in a control group of 8 healthy, young individuals. Two trace doses of [3H]metoprolol were given i.v., first concomitantly with a single oral 50 mg dose of cold metoprolol, and second, with the morning dose after 2 weeks of treatment with 50 mg b.d. In the elderly, the mean AUC increased by about 45% (p<0.05) over the treatment period, while in the control group the mean AUC was 18% greater (p<0.05) on Day 14 than on Day 1. In the elderly, changes both in pre-systemic elimination and in total body clearance accounted for the elevation of the AUC, whereas reduced first-pass effect appeared to be the major cause of the increased steady-state plasma level in the control group. With the exception of the volume term, V β , the pharmacokinetic parameters were not significantly different between the elderly and the young individuals. For this reason, almost identical steady-state plasma levels were attained in the two groups. The results suggest that age-related physiological changes may have some minor effects on the pharmacokinetics of metoprolol, and also that the changes do not lead to significantly altered plasma concentrations compared to those in young individuals.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Landahl S, Steen B (1981) Läkemedelskonsumtion hos 70-och 75-åringar. Longitudinella data från en populationsundersökning. Läkartidningen 78 [25]: 2458–2460
Lundborg P, Steen B (1976) Plasma levels and effect on heart rate and blood pressure of metoprolol after acute oral administration in twelve geriatric patients. Acta Med Scand 200: 397–402
Kendall MJ, Brown D, Yates RA (1977) Plasma metoprolol concentrations in young, old and hypertensive subjects. Br J Clin Pharmacol 4: 497–499
Castleden CM, Kaye CM, Parsons RL (1975) The effect of age on plasma levels of propranolol and practolol in man. Br J Clin Pharmacol 2: 303–306
Schneider RW, Bishop H, Yates RA, Quarterman CP, Kendall M (1980) Effect of age on plasma propranolol levels. Br J Clin Pharmacol 10: 169–170
Ishizaki T, Hirayama H, Tawara K, Nakaya H, Sato M, Sato K (1980) Pharmacokinetics and pharmacodynamics in young normal and elderly hypertensive subjects: a study using sotalol as a model drug. J Pharmacol Exp Ther 212: 173–181
Kelly JG, McGarry K, O'Malley K, O'Brien ET (1982) Bioavailability of labetalol increases with age. Br J Clin Pharmacol 14: 304–305
Quarterman CP, Kendall MJ, Jack DB (1981) The effect of age on the pharmacokinetics of metoprolol and its metabolites. Br J Clin Pharmacol 11: 287–294
Kendall MJ, John VA, Quarterman CP, Welling PG (1980) A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metoprolol. Eur J Clin Pharmacol 17: 87–92
Regårdh CG, Landahl S, Larsson M, Lundborg P, Steen B, Hoffmann K-J, Lagerström PO (1983) Pharmacokinetics of metoprolol and its metabolite α-OH-metoprolol in healthy non-smoking, elderly individuals. Eur J Clin Pharmacol 24: 221–226
Castleden CM, George CF (1979) The effect of ageing on hepatic clearance of propranolol. Br J Clin Pharmacol 7: 49–54
Vestal RE, Wood AJJ, Shand DG (1979) Reduced β-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 26: 181–186
Kornhauser DM, Wood AJJ, Vestal RE, Wilkinson GR, Branch RA, Shand DG (1978) Biological determinants of propranolol disposition in man. Clin Pharmacol Ther 23: 165–174
Kendall MJ, Quarterman CP (1982) The effect of age on the pharmacokinetics of oxprenolol. Int J Clin Pharmacol Ther Toxicol 20: 101–104
Myers MG, Thiessen JJ (1980) Metoprolol kinetics and dose response in hypertensive patients. Clin Pharmacol Ther 21: 756–762
Evans GH, Shand DG (1973) Disposition of propranolol. Drug accumulation and steady-state concentrations during chronic oral administration in man. Clin Pharmacol Therap 14: 487–493
Ervik M, Hoffmann K-J, Kylberg-Hanssen K (1981) Selected ion monitoring of metoprolol and two metabolites in plasma and urine using deuterated internal standards. Biomed Mass Spectrom 8: 322–326
Metzler CM, Elfring L, McEwen AJ (1974) A user's manual for NONLIN and associated programs. Research Biostatistics, The Upjohn Company, Kalamazoo, Mich
Yeh KC, Kwan KC (1978) A comparison of numeral algorithms by trapezoidal, lagrange and spline approximation. J Pharmacokinet Biopharm 6: 79–98
Rowland MV, Tozer TN (1980) Influence of blood flow, changes in pharmacokinetic parameters. In: Clinical pharmacokinetics — Concepts and applications. Lea and Febiger, Philadelphia, pp 145–147
Regårdh CG, Ek L, Hoffmann K-J (1979) Plasma levels and β-blocking effect of α-hydroxymetoprolol — metabolite of metoprol — in the dog. J Pharmacokinet Biopharm 7: 471–479
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Larsson, M., Landahl, S., Lundborg, P. et al. Pharmacokinetics of metoprolol in healthy, elderly, non-smoking individuals after a single dose and two weeks of treatment. Eur J Clin Pharmacol 27, 217–222 (1984). https://doi.org/10.1007/BF00544048
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00544048